首页> 外文期刊>BMC Infectious Diseases >Prevalence of molecular markers associated with drug resistance of Plasmodium vivax isolates in Western Yunnan Province, China
【24h】

Prevalence of molecular markers associated with drug resistance of Plasmodium vivax isolates in Western Yunnan Province, China

机译:中国西部云南省疟原虫耐药性分子标志物的分子标记患病率

获取原文
       

摘要

Plasmodium vivax is the most widely distributed malaria parasite, and its drug resistance poses?unique challenges to malaria elimination. The Greater Mekong Subregion (GMS) is known as the global epicenter of multidrug resistance. Surveillance of molecular markers associated with drug resistance in this area will help to inform drug policy. Dry blood spots from 58 patients out of 109 with P. vivax infection between 2017, December and 2019, March were obtained from Yingjiang County, Yunnan Province, along the China–Myanmar border. Pvdhfr, Pvdhps, Pvmdr1 and Pvcrt-o were amplified and sequenced to assess gene mutations. The polymorphism and prevalence of these molecular markers were analyzed. Mutations in Pvdhfr at codons 57, 58, 61, 99 and 117 were detected in 27.59, 48.28, 27.59, 32.76 and 48.28% of the isolates, respectively. Single mutant haplotype (I13F57S58T61S99S117I173) was the most frequent (29.31%, 17/58), followed by double mutant haplotype (20.69%, 12/58). Of three types of tandem repeat variations of Pvdhfr, deletion type was the most common. Pvdhps showed a lower prevalence among mutation genotypes. Single mutant was dominant and accounted for 34.48% (20/58). Prevalence of Pvmdr1 mutations at codons 958 and 1076 were 100.00% and 84.48%, respectively. The proportion of double and single mutant types was 84.48% (49/58) and 15.52% (9/58), respectively. Eleven samples (18.97%, 11/58) showed K10 “AAG” insertion in chloroquine resistance transporter gene Pvcrt-o. There was moderate diversity of molecular patterns of resistance markers of Pvdhfr, Pvdhps, Pvmdr1 and Pvcrt-o in?imported P. vivax cases to Yingjiang county in Western Yunnan, along the China–Myanmar border. Prevalence and molecular pattern of candidate drug resistance markers Pvdhfr, Pvdhps, Pvmdr1 and Pvcrt-o were demonstrated in this current study, which would help to update drug policy.
机译:疟原虫疟原虫是最广泛分布的疟疾寄生虫,其耐药性造成姿势?对疟疾消除的独特挑战。大湄公河次区域(GMS)被称为多药抗性的全球震中。与该地区耐药相关的分子标记的监测将有助于为药物政策提供信息。 58名患者的干血斑在109例中,2017年12月和2019年间,3月份沿中国 - 缅甸边境从云南省英江县获得。扩增PVDHFR,PVDHPS,PVMDR1和PVCRT-O,以评估基因突变。分析了这些分子标记物的多态性和患病率。在27.59,48.28,27.59,32.59,32.76和48.28%的分离物中检测到密码子57,58,61,99和117处的PVDHFR中的突变。单个突变单倍型(I13F57S58T61S99S19S117I173)是最常见的(29.31%,17/58),其次是双突变单倍型(20.69%,12/58)。 PVDHFR的三种类型的串联重复变化,删除类型最为常见。 PVDHPS在突变基因型中表现出较低的患病率。单突变体占主导地位,占34.48%(20/58)。密码子958和1076处PVMDR1突变的患病率分别为100.00%和84.48%。双和单突变体类型的比例分别为84.48%(49/58)和15.52%(9/58)。 11个样品(18.97%,11/58)显示K10“AAG”插入氯喹耐药仪基因PVCRT-O中。 PVDHFR,PVDHPS,PVMDR1和PVCRT-O中的抗性标志物的分子模式中适中的多样性?沿中国缅甸边境进口云南西江县进口的P.Vivax案件。本前研究证明了候选药物抗性标志物PVDHFR,PVDHPS,PVMDR1和PVCRT-O的患病率和分子模式,这将有助于更新药物政策。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号